These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 25701184

  • 21. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
    Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Yamamoto H, Kunii N, Sakurai D, Fujimura T, Nakazawa K, Yasueda H.
    Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
    [Abstract] [Full Text] [Related]

  • 22. [A novel murine model of Japanese cedar pollinosis for characterizing allergen-specific sublingual immunotherapy].
    Tofukuji S, Ishida S, Katayama K.
    Nihon Yakurigaku Zasshi; 2017; 150(2):68-71. PubMed ID: 28794300
    [No Abstract] [Full Text] [Related]

  • 23. Repeated antigen painting and sublingual immunotherapy in mice convert sublingual dendritic cell subsets.
    Zhang C, Ohno T, Kang S, Takai T, Azuma M.
    Vaccine; 2014 Sep 29; 32(43):5669-76. PubMed ID: 25168308
    [Abstract] [Full Text] [Related]

  • 24. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
    Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Kunii N, Yamamoto H, Sakurai D, Hanazawa T.
    Arerugi; 2008 May 29; 57(5):558-61. PubMed ID: 18520178
    [Abstract] [Full Text] [Related]

  • 25. Effect of Japanese cedar-specific sublingual immunotherapy on allergen-specific TH2 cell counts in blood.
    Nomura T, Suzuki M, Yokota M, Nakamura Y, Ozeki K, Ito Y, Tsuge I, Saitoh S.
    Ann Allergy Asthma Immunol; 2016 Jul 29; 117(1):72-78.e4. PubMed ID: 27156747
    [Abstract] [Full Text] [Related]

  • 26. Measurement of Japanese cedar pollen-specific IgE in nasal secretions.
    Sakaida H, Masuda S, Takeuchi K.
    Allergol Int; 2014 Sep 29; 63(3):467-73. PubMed ID: 24957114
    [Abstract] [Full Text] [Related]

  • 27. Effects of sublingual immunotherapy with tablets or drops containing Japanese cedar pollen antigens on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis.
    Fujii T, Kitamura Y, Kamimura S, Takeda N.
    J Med Invest; 2022 Sep 29; 69(1.2):97-100. PubMed ID: 35466153
    [Abstract] [Full Text] [Related]

  • 28. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE, Monasterolo G, Coco G, Operti D.
    Int Arch Allergy Immunol; 2005 Oct 29; 138(2):105-10. PubMed ID: 16174987
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY IN THE SECOND TREATED YEAR FOR 133 PATIENTS WITH JAPANESE CEDAR POLLINOSIS IN 2016].
    Yuta A, Ogawa Y, Suzuki Y, Arikata M, Kozaki H, Shimizu T, Ohta N.
    Arerugi; 2016 Oct 29; 65(9):1209-1218. PubMed ID: 27885205
    [Abstract] [Full Text] [Related]

  • 31. Safety and efficacy of rice seed-based oral allergy vaccine for Japanese cedar pollinosis in Japanese monkeys.
    Saito S, Takagi H, Wakasa Y, Ozawa K, Takaiwa F.
    Mol Immunol; 2020 Sep 29; 125():63-69. PubMed ID: 32650161
    [Abstract] [Full Text] [Related]

  • 32. Current status of sublingual immunotherapy for allergic rhinitis in Japan.
    Masuyama K, Matsuoka T, Kamijo A.
    Allergol Int; 2018 Jul 29; 67(3):320-325. PubMed ID: 29805085
    [Abstract] [Full Text] [Related]

  • 33. Immunological effects of sublingual immunotherapy with Japanese cedar pollen extract in patients with combined Japanese cedar and Japanese cypress pollinosis.
    Kikuoka H, Kouzaki H, Matsumoto K, Arai H, Yamamoto S, Tojima I, Shimizu S, Miyashita H, Ogawa Y, Osada T, Okano M, Yuta A, Shimizu T.
    Clin Immunol; 2020 Jan 29; 210():108310. PubMed ID: 31743749
    [Abstract] [Full Text] [Related]

  • 34. Japanese cedar and cypress pollinosis updated: New allergens, cross-reactivity, and treatment.
    Osada T, Okano M.
    Allergol Int; 2021 Jul 29; 70(3):281-290. PubMed ID: 33962864
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Adverse Events of Sublingual Immunotherapy in 207 Patients with Japanese Cedar Pollinosis].
    Ogawa Y, Yuta A, Arikata M, Kozaki H, Ohta N, Suzuki Y, Shimizu T.
    Nihon Jibiinkoka Gakkai Kaiho; 2015 Dec 29; 118(12):1429-35. PubMed ID: 26964395
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.